8-K - ARVINAS, INC. (0001655759) (Filer)
Published . Updated .
Key takeaways
- 8-K - ARVINAS filed an 8-K with the SEC on Nov 3 (a notice of a material company event).
- Exposed: ARVN
- Market reaction: ARVN −14.9% after three sessions
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
8-K - ARVINAS filed an 8-K with the SEC on Nov 3 (a notice of a material company event).
Directly affected
- ARVN Arvinas-2.8% 6d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Arvinas belongs to, so it often moves with news about it.
- LLY Eli Lilly and+23.6% 30d
Eli Lilly and is a peer of Arvinas in pharmaceutical preparations; rivals often move on the same news.
- JNJ Johnson & Johnson+8.5% 30d
Johnson & Johnson is a peer of Arvinas in pharmaceutical preparations; rivals often move on the same news.
- ABBV AbbVie+12.2% 30d
AbbVie is a peer of Arvinas in pharmaceutical preparations; rivals often move on the same news.
- MRK Merck+4.3% 30d
Merck is a peer of Arvinas in pharmaceutical preparations; rivals often move on the same news.
- ABT Abbott Laboratories+13.3% 30d
Abbott Laboratories is a peer of Arvinas in pharmaceutical preparations; rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| ARVN | -1.06% | +4.98% | base | -5.77% | -1.26% | -13.14% | -14.93% |
| XLV | -2.95% | -0.31% | base | -0.34% | +2.73% | +0.31% | +0.13% |
| LLY | -9.22% | -2.71% | base | -0.17% | +0.45% | -2.64% | -4.04% |
| JNJ | -0.68% | +1.70% | base | -1.63% | +2.13% | +0.67% | +2.13% |
| ABBV | -0.84% | +0.67% | base | -1.01% | +1.62% | +0.12% | +0.94% |
| MRK | -4.45% | -1.43% | base | -2.55% | +1.29% | -0.75% | -1.14% |
| ABT | -6.49% | -5.19% | base | -0.80% | +5.08% | +2.96% | -0.28% |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Filed: 2026-11-03 AccNo: 0001628280-26-069101 Size: 9 MB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
Arvinas (ARVN) since “8-K - ARVINAS, INC. (0001655759) (Filer),” compared with the market
Since the first closing price after “8-K - ARVINAS, INC. (0001655759) (Filer),” Arvinas (ARVN) is -7.26%.
| Company | When | Move | Status |
|---|---|---|---|
| ABBV | that day | -1.01% | final price |
| ABBV | the next day | +1.62% | final price |
| ABBV | two days later | +0.12% | final price |
| ABBV | three days later | +0.94% | final price |
| ABBV | three days earlier | +0.67% | final price |
| ABBV | five days earlier | -0.84% | final price |
| ABT | that day | -0.80% | final price |
| ABT | the next day | +5.08% | final price |
| ABT | two days later | +2.96% | final price |
| ABT | three days later | -0.28% | final price |
| ABT | three days earlier | -5.19% | final price |
| ABT | five days earlier | -6.49% | final price |
| Arvinas (ARVN) | that day | -5.77% | final price |
| Arvinas (ARVN) | the next day | -1.26% | final price |
| Arvinas (ARVN) | two days later | -13.14% | final price |
| Arvinas (ARVN) | three days later | -14.93% | final price |
| Arvinas (ARVN) | three days earlier | +4.98% | final price |
| Arvinas (ARVN) | five days earlier | -1.06% | final price |
| JNJ | that day | -1.63% | final price |
| JNJ | the next day | +2.13% | final price |
| JNJ | two days later | +0.67% | final price |
| JNJ | three days later | +2.13% | final price |
| JNJ | three days earlier | +1.70% | final price |
| JNJ | five days earlier | -0.68% | final price |
| LLY | that day | -0.17% | final price |
| LLY | the next day | +0.45% | final price |
| LLY | two days later | -2.64% | final price |
| LLY | three days later | -4.04% | final price |
| LLY | three days earlier | -2.71% | final price |
| LLY | five days earlier | -9.22% | final price |
| MRK | that day | -2.55% | final price |
| MRK | the next day | +1.29% | final price |
| MRK | two days later | -0.75% | final price |
| MRK | three days later | -1.14% | final price |
| MRK | three days earlier | -1.43% | final price |
| MRK | five days earlier | -4.45% | final price |
| XLV | that day | -0.34% | final price |
| XLV | the next day | +2.73% | final price |
| XLV | two days later | +0.31% | final price |
| XLV | three days later | +0.13% | final price |
| XLV | three days earlier | -0.31% | final price |
| XLV | five days earlier | -2.95% | final price |
Congressional trades in the stocks in this story
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 60 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Johnson & Johnson (JNJ) (held by a spouse), worth $15,001 - $50,000 on 7 Oct 2026. That is 27 days before publication. Filed 5 Nov 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 30 Sep 2026. That is 34 days before publication. Filed 30 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 39 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought AbbVie (ABBV) (held by a spouse), worth $1,001 - $15,000 on 7 Oct 2026. That is 27 days before publication. Filed 5 Nov 2026. View the filing.
- Rep. Pete Sessions sold AbbVie (ABBV), worth $15,001 - $50,000 on 14 Sep 2026. That is 50 days before publication. Filed 18 Sep 2026. View the filing.
- Rep. Rohit Khanna sold AbbVie (ABBV) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 60 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 40 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Merck (MRK), worth $15,001 - $50,000 on 19 Aug 2026. That is 76 days before publication. Filed 9 Sep 2026. View the filing.
- Rep. Rohit Khanna bought Abbott Laboratories (ABT) (held by a spouse), worth $1,001 - $15,000 on 7 Oct 2026. That is 27 days before publication. Filed 5 Nov 2026. View the filing.
- Rep. Pete Sessions sold Abbott Laboratories (ABT) (held by a spouse), worth $50,001 - $100,000 on 2 Oct 2026. That is 32 days before publication. Filed 27 Oct 2026. View the filing.
- Rep. Gilbert Cisneros bought Abbott Laboratories (ABT), worth $1,001 - $15,000 on 18 Sep 2026. That is 46 days before publication. Filed 12 Oct 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Arvinas (ARVN)
Companies carried with this story
- ARVN Arvinas
In “8-K - ARVINAS, INC. (0001655759) (Filer),” Arvinas (ARVN) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> ARVN
How “8-K - ARVINAS, INC. (0001655759) (Filer)” reaches Arvinas (ARVN)
On 3 Nov 2026, “8-K - ARVINAS, INC. (0001655759) (Filer)” is the story that connects Arvinas (ARVN) to this story.
The link for Arvinas (ARVN) is this: SEC 8-K filing -> direct issuer disclosure -> ARVN
Price levels for Arvinas (ARVN)
ARVN traded between 6.34 and 7.68 across 6 sessions. The latest close on file is 6.90.
A simple score for Arvinas (ARVN)
14 out of 100
“8-K - ARVINAS, INC. (0001655759) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.